Skip to content
BMYBristol-Myers Squibb Company

BMY Earnings

Bristol-Myers Squibb Company next reports earnings on October 29, 2026. Track record: 4/4 beats.

Next Earnings In

88Days
:
14Hours
:
42Min
:
21Sec

Thursday, October 29, 2026

Current Price

$65.31

EPS Estimate

Earnings Per Share

$1.72

+5.3% YoY

Trailing EPS

Last 12 months earnings

$4.54

Beat Rate

4/4

100%

Forward P/E

Price-to-Earnings ratio

10.1

Margin: 18.9%

Analyst Rating

Hold

23 analysts

Analyst Sentiment

Hold23 analysts
Target: $64.91-0.6%Full analysis →

Earnings History

4/4 Beats
QuarterEPS Est.EPS ActualSurpriseResult
2026-06-30$1.60$2.04+27.7%Beat
2026-03-31$1.42$1.58+11.2%Beat
2025-12-31$1.20$1.26+4.6%Beat
2025-09-30$1.52$1.63+7.6%Beat

Growth Estimates

PeriodEPS Est.Growth
Current Qtr(0q)$1.72+5.3%
Next Qtr(+1q)$1.58+25.1%
Current Year(0y)$6.83+11.0%
Next Year(+1y)$6.47-5.3%

Next Quarter Estimates

EPS Estimate

Earnings Per Share

$1.72

Revenue Estimate

$12.7B

Annual EPS Est.

$6.83

+11.0% YoY

BMY Earnings FAQ

When is BMY's next earnings date?

Bristol-Myers Squibb Company (BMY) is expected to report earnings on October 29, 2026. The consensus EPS estimate is $1.72.

Does BMY usually beat earnings estimates?

Bristol-Myers Squibb Company has beaten Wall Street EPS estimates in 4 of the last 4 quarters (100% beat rate).

What is BMY's trailing EPS?

Bristol-Myers Squibb Company's trailing twelve-month EPS is $4.54. This is calculated from the last four quarters of reported earnings.

What do analysts think about BMY?

23 Wall Street analysts cover Bristol-Myers Squibb Company. The consensus rating is "Hold" with an average price target of $64.91, implying 0.6% downside from the current price.